You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Platelet-Derived Growth Factor Receptor Alpha

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

FLT3-ITD Mutation, FLT3/TKD Mutation, PDGFR-Alpha D842V Trial in Genova (Crenolanib besylate)

Available
  • FLT3-ITD Mutation
  • +3 more
  • Crenolanib besylate
  • Genova, Italy
    Ospedale Policlinico San Martino
May 21, 2020

Glioma, High Grade Glioma, Pontine Tumors Trial in Ann Arbor (Dasatinib, Everolimus)

Terminated
Has Results
  • Glioma
  • +2 more
  • Ann Arbor, Michigan
    University of Michigan Cancer Center
Sep 26, 2022

Gingival Recession, Platelet Derived Growth Factor Trial in Ann Arbor (Root coverage procedures)

Completed
  • Gingival Recession
  • Platelet Derived Growth Factor
  • Root coverage procedures
  • Ann Arbor, Michigan
    University of Michigan School of Dentistry
Sep 26, 2021

Dental Implant, Bone Loss Trial in Birmingham (Allograft particles hydrated with rhPDGF, Allograft particles hydrated in a

Recruiting
  • Dental Implant
  • Bone Loss
  • Allograft particles hydrated with rhPDGF
  • Allograft particles hydrated in a conventional way with saline.
  • Birmingham, Alabama
    Unversity of Alabama at Birmingham, School of Dentistry
Aug 25, 2021

Healthy Volunteers Trial (REGN13335, Matching Placebo)

Not yet recruiting
  • Healthy Volunteers
  • (no location specified)
Nov 13, 2023

Endometrial Development Trial in Leioa (Growth Factor, Platelet-Derived)

Terminated
  • Endometrial Development
  • Growth Factor, Platelet-Derived
  • Leioa, Vizcaya, Spain
    IVI Bilbao
Mar 29, 2022

HER2-negative Early Breast Cancer Trial in Beijing (neoadjuvant chemo upon in vitro PTC drug sensitivity screening for triple

Recruiting
  • HER2-negative Early Breast Cancer
  • neoadjuvant chemotherapy upon in vitro PTC drug sensitivity screening for triple negative breast cancer
  • neoadjuvant chemotherapy upon in vitro PTC drug sensitivity screening for luminal like breast cancer
  • Beijing, China
    Peking University People's Hospital
Mar 27, 2022

A NIS of Alpelisib in Combination With Fulvestrant in

Not yet recruiting
  • Hormone Receptor Positive HER2 Negative Breast Cancer With a PIK3CA Mutation
  • Alpelisib
  • Fulvestrant
  • (no location specified)
Aug 9, 2022

Ovarian Tumors Trial in United States (Olaratumab, liposomal doxorubicin)

Completed
Has Results
  • Ovarian Neoplasms
  • Olaratumab
  • liposomal doxorubicin
  • Joliet, Illinois
  • +5 more
Sep 10, 2019

Tooth Extraction, Immediate Implant Placement Trial in Iowa City (Xenogeneic Volume-Stable Collagen (VCMX) graft with growth

Not yet recruiting
  • Tooth Extraction
  • Immediate Implant Placement
  • Xenogeneic Volume-Stable Collagen (VCMX) graft with growth factor-BB
  • Iowa City, Iowa
    University of Iowa College of Dentistry and Dental Clinics
Sep 8, 2023

Chronic Myelomonocytic Leukemia, Chronic Myeloid Leukemia, Polycythemia Vera Trial in Houston (Imatinib Mesylate (Gleevec))

Completed
Has Results
  • Chronic Myelomonocytic Leukemia
  • +4 more
  • Imatinib Mesylate (Gleevec)
  • Houston, Texas
    UT MD Anderson Cancer Center
Dec 7, 2021

Eosinophilic Myeloid Tumor, Hypereosinophilic Syndrome Trial run by the National Institute of Allergy and Infectious Diseases

Recruiting
  • Eosinophilic Myeloid Neoplasm
  • Hypereosinophilic Syndrome
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer Trial in Singapore (Oral lenvatinib + Intravenous (IV)

Not yet recruiting
  • Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer
  • Oral lenvatinib + Intravenous (IV) pembrolizumab + Oral letrozole
  • Singapore, Singapore
    National Cancer Centre Singapore
Oct 13, 2022

Glioma Trial in La Jolla (nilotinib)

Completed
Has Results
  • Glioma
  • La Jolla, California
    The Rebecca and John Moores UCSD Cancer Center
Apr 27, 2020

Periodontitis Trial (PRF)

Not yet recruiting
  • Periodontitis
  • PRF
  • (no location specified)
May 25, 2023

Implant Complication Trial in Boston (Prosthetic-surgical approach + autogenous graft, Prosthetic-surgical approach + graft

Recruiting
  • Implant Complication
  • Prosthetic-surgical approach + autogenous graft
  • Prosthetic-surgical approach + graft substitute
  • Boston, Massachusetts
    Harvard School of Dental Medicine
Jan 4, 2023

Renal Cell Carcinoma Trial in Iowa City (Lenvatinib, Everolimus, Partial or Radical Cytoreductive Nephrectomy)

Recruiting
  • Renal Cell Carcinoma
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
May 4, 2022

Leiomyosarcoma, Liposarcoma, Soft Tissue Sarcoma Adult Trial in Taipei (Eribulin, Lenvatinib)

Active, not recruiting
  • Leiomyosarcoma
  • +3 more
  • Taipei, Taiwan
  • +1 more
Dec 27, 2022

Platelet-Rich Fibrin Trial in Erzurum (periodontal surgical procedure (open flap debridement), periodontal surgical procedure

Completed
  • Platelet-Rich Fibrin
  • periodontal surgical procedure (open flap debridement)
  • periodontal surgical procedure (OFD +autogenous Titanium-prepared platelet-rich fibrin (OFD+ T-PRF))
  • Erzurum, Turkey
    Atatürk University Faculty of Dentistry Department of Peirodonto
Jun 4, 2022

Dry Eye Disease Trial in Oslo (Thealoz Duo (combination of trehalose and hyaluronate) eye drop and Hyabak (hyaluronate) eye

Recruiting
  • Dry Eye Disease
  • Thealoz Duo (combination of trehalose and hyaluronate) eye drop and Hyabak (hyaluronate) eye drop
  • Oslo, Norway
    The Norwegian Dry Eye Clinic
Jun 27, 2022

Dental Implant Failure Nos Trial in Minya (Drug: Growth Factors (CGF), Drug: Growth Factors (PRGF), Surgery: Dental Implant

Recruiting
  • Dental Implant Failure Nos
  • Drug: Growth Factors (CGF)
  • +4 more
  • Minya, Egypt
    Faculty of Dentistry Minia University
Oct 26, 2022

Tendinopathy, Patellar Ligament, Platelet-Rich Plasma Trial in Columbus (Platelet Rich Plasma, Platelet Rich Plasma plus IGF)

Completed
  • Tendinopathy
  • +2 more
  • Platelet Rich Plasma
  • Platelet Rich Plasma plus IGF
  • Columbus, Ohio
    The Ohio State University Sports Medicine Center
Aug 4, 2022

Inflammatory and Anti-Inflammatory Gene Expressions in Liver

Active, not recruiting
  • Liver Transplant; Complications
  • +3 more
  • Molecular Immunology , gene expressions
  • Malatya, Turkey
    İnönü University
May 2, 2023

Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Shanghai (Docetaxel, Carboplatin, Epirubicin)

Recruiting
  • Hormone Receptor Positive HER-2 Negative Breast Cancer
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Jun 12, 2023

NSCLC Trial in Australia, China, Korea, Republic of (AZD9291)

Active, not recruiting
Has Results
  • Non-Small Cell Lung Cancer
  • Kogarah, Australia
  • +29 more
Oct 20, 2022